CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas

This publication has 39 references indexed in Scilit:

• Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
  Science, 1994
• Pentostatin
  Drugs, 1993
• Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
  Science, 1993
• A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.
  The Journal of Experimental Medicine, 1993
• Recent Results on the Biology of Hodgkin and Reed-Sternberg cells: II. Continuous Cell Lines
  Leukemia & Lymphoma, 1993
• Biochemical characterization of CD26 (dipeptidyl peptidase IV): Functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies
  Molecular Immunology, 1992
• Ki-1 Positive Large Cell Lymphoma
  The American Journal of Surgical Pathology, 1988
• Isolation and characterization of dipeptidyl peptidase IV from human meconium
  FEBS Letters, 1985
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
  Journal of Histochemistry & Cytochemistry, 1984
• Dipeptidylaminopeptidase IV (DAP IV) Activity in Normal and Malignant T‐Cell Subsets as Defined by Monoclonal Antibodies
  Scandinavian Journal of Haematology, 1983